AbbVie Sees Bullish $1.5M Call Bet as Stock Breaks Above 52-Week High

By TrendSpider Editor

A single unusual options contract worth $1,498,750 in premium hit the tape for AbbVie Inc. (ABBV) on Wednesday, signaling that at least one large trader is positioning for a significant move higher in the pharmaceutical giant over the next 15 months. ABBV shares are trading at $272.085, up 1.98% on

AbbVie Sees Bullish $1.5M Call Bet as Stock Breaks Above 52-Week High

A single unusual options contract worth $1,498,750 in premium hit the tape for AbbVie Inc. (ABBV) on Wednesday, signaling that at least one large trader is positioning for a significant move higher in the pharmaceutical giant over the next 15 months. ABBV shares are trading at $272.085, up 1.98% on the session, and notably above the 52-week high of $269.39, suggesting the stock is breaking out into fresh all-time high territory. With the 52-week low sitting at $191, the stock has made a substantial run, and this options activity suggests sophisticated money is betting that rally has further to go.

Key Drivers of the ABBV Stock Move

• Main Catalyst: A single call options contract was flagged as unusual, targeting the $300 strike with a January 21, 2028 expiration. The contract carried $1,498,750 in total premium on a size of 550 contracts, representing 61% open interest and sitting out of the money relative to the current share price of $272.085.
• Bull Case: The $300 strike call expiring in January 2028 implies a trader expects ABBV to rise roughly 10.3% above current levels before expiration. The decision to pay $1,498,750 in premium with a 15-plus month runway reflects a high-conviction, longer-duration bullish thesis. The fact that today's price of $272.085 is already above the prior 52-week high of $269.39 adds technical momentum to support that view.
• Bear Case: The contract is currently out of the money, meaning the full $1,498,750 in premium is at risk if ABBV fails to close above $300 by January 21, 2028. The open interest ratio of 61% also suggests this position is largely new rather than a roll of an existing trade, adding uncertainty around intent and potential hedging dynamics that could work against a purely directional read.

The forward setup for ABBV is notable given that the stock is printing above its prior 52-week high of $269.39 for the first time, a level that now flips to technical support. The $300 strike targeted in today's unusual options flow represents a logical area of resistance for traders monitoring round-number levels and prior extension zones. AbbVie operates in the large-cap biopharmaceutical space, where pipeline catalysts, patent timelines, and regulatory decisions can create sharp directional moves over a multi-quarter horizon, all of which align with the 15-month duration of the flagged contract. Investors will want to monitor whether additional unusual activity builds around the $300 strike in the coming sessions, as a cluster of similar positioning would strengthen the bullish signal from today's single large print.

ABBV Unusual Options Activity

One contract was flagged as unusual in today's session:

• Type: Call | Strike: $300 | Expiry: January 21, 2028 | Volume (Size): 550 contracts | Open Interest: 61% | Position: Out of the money

Total premium across all unusual contracts came to $1,498,750. There were zero put contracts flagged in today's scan, making this a one-sided bullish print with no offsetting bearish positioning detected in the unusual flow data.

ABBV Seasonality

October has historically been an active month for pharmaceutical stocks as companies approach year-end portfolio rebalancing and fourth-quarter earnings setups. A January 2028 expiration gives this position significant runway through multiple potential catalysts, including two full annual earnings cycles and any pipeline readouts that could emerge between now and expiration.

ABBV Relative Performance

ABBV's 1.98% gain on Wednesday puts it in a position of strength relative to what would be expected on a broad market average session. More significantly, the stock's current price of $272.085 marks a new high relative to its 52-week range of $191 to $269.39, meaning ABBV is outperforming its own trailing year of price history and breaking into uncharted territory, a dynamic that often attracts additional momentum-driven interest from both institutional and options traders.